Literature DB >> 2526228

Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1.

C L Ruegg1, C R Monell, M Strand.   

Abstract

Peptides were synthesized that contained sequences from two regions (env amino acids [aa] 581 to 597 and 655 to 671) of the transmembrane protein gp41 and one region of the external envelope glycoprotein gp120 (aa 457 to 464) of human immunodeficiency virus type 1. Selection of these sequences was based on their homology to the highly conserved and immunosuppressive sequence contained within the transmembrane proteins p15E and gp21 of animal and human retroviruses, respectively. Peptide aa581-597 was found to specifically inhibit human and murine lymphoproliferation, whereas peptides aa655-671 and aa457-464 had no activity. These results suggest a mechanism by which human immunodeficiency virus type 1 gp41 exerts a direct immunosuppressive effect in vivo, analogous to that postulated for p15E and gp21, which could contribute to the immune dysfunction observed in patients suffering from acquired immunodeficiency syndrome. It is of particular interest that the sequence aa 584 to 609, shown to contain B- and T-helper-cell epitopes, overlaps with the sequence aa 581 to 597 that is shown here to inhibit lymphoproliferation. The potential implications of this overlap of immunologic activities are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526228      PMCID: PMC250896     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

Review 1.  The structure of T-cell epitopes.

Authors:  A M Livingstone; C G Fathman
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

2.  Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome.

Authors:  H J Thiel; H Schwarz; P Fischinger; D Bolognesi; W Schäfer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Nucleotide sequence of the AIDS virus, LAV.

Authors:  S Wain-Hobson; P Sonigo; O Danos; S Cole; M Alizon
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

4.  Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

Authors:  G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

5.  The immune system in AIDS.

Authors:  J Laurence
Journal:  Sci Am       Date:  1985-12       Impact factor: 2.142

6.  Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3.

Authors:  I Clark-Lewis; R Aebersold; H Ziltener; J W Schrader; L E Hood; S B Kent
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

7.  Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.

Authors:  J J Wang; S Steel; R Wisniewolski; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients.

Authors:  E C DeFreitas; M Sandberg-Wollheim; K Schonely; M Boufal; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response.

Authors:  T C Chanh; R C Kennedy; P Kanda
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

10.  Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.

Authors:  S Pahwa; R Pahwa; C Saxinger; R C Gallo; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more
  35 in total

Review 1.  New therapeutic strategies targeting transmembrane signal transduction in the immune system.

Authors:  Alexander B Sigalov
Journal:  Cell Adh Migr       Date:  2010-04-24       Impact factor: 3.405

2.  The immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 binds to human monocytes and B cells.

Authors:  Michael Mühle; Tobias Kroniger; Kerstin Hoffmann; Joachim Denner
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

3.  HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation.

Authors:  Francisco J Quintana; Doron Gerber; Sally C Kent; Irun R Cohen; Yechiel Shai
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

4.  Neutralizing antibodies and antigens in AIDS.

Authors:  S G Norley; R Kurth
Journal:  Infection       Date:  1991       Impact factor: 3.553

5.  Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus.

Authors:  Y H Chong; J M Ball; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  The SCHOOL of nature: IV. Learning from viruses.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-10

7.  Inhibition of lymphoproliferation and protein kinase C by synthetic peptides with sequence identity to the transmembrane and Q proteins of visna virus.

Authors:  C L Ruegg; J E Clements; M Strand
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Glucocorticoid-mediated immunomodulation: hydrocortisone enhances immunosuppressive endogenous retroviral protein (p15E) expression in mouse immune cells.

Authors:  M Fiegl; E Strasser-Wozak; S Geley; A Gsur; J Drach; R Kofler
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

9.  HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation.

Authors:  Tomer Cohen; Shmuel Jaffe Cohen; Niv Antonovsky; Irun R Cohen; Yechiel Shai
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

10.  Novel mechanistic insights into viral modulation of immune receptor signaling.

Authors:  Alexander B Sigalov
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.